





To the Editor: The report of a 
human cutaneous leishmaniasis case 
acquired in Clairvaux-les-lacs (1) 
led us to carry out an investigation 
with the veterinary clinics in Jura 
Department, France. Clairvaux-les-
lacs is a lakeside resort located in 
Jura, one of the areas in France with 
the coldest average temperatures, and 
is clearly located outside the usual 
leishmaniasis-endemic area. At least 
31 cases of canine leishmaniasis were 
diagnosed by veterinary clinics in Jura 
during 2007–2011. Because these 
dogs were native of or traveled in the 
leishmaniasis-endemic area along the 
Mediterranean Sea, all veterinarians 
considered the infections as acquired 
outside Jura.
Although phlebotomine sand fl ies 
have not been reported in Jura to date, 
Phlebotomus perniciosus sand fl ies, 
proven vectors of leishmaniasis, have 
been found in 2 areas neighboring 
Jura: Côte-d’Or and Saône-et-Loire 
(2,3). We have also recently caught 
P. mascittii sand fl ies, a species with 
an unknown vectorial competence, 
in the Swiss region of Jura, Alsace, 
Champagne-Ardennes, and Belgium. 
Therefore, the presence of sand fl ies 
in Jura, particularly in wet and milder 
microclimatic areas (as Clairvaux-les-
lacs), is likely, and canine infections 
could have been acquired locally.
A recent model predicted that 
new at-risk areas are mostly located in 
western France along the Atlantic coast 
(4). In accordance with this model, 
we report new foci of autochthonous 
canine leishmaniasis in Deux Sèvres, 
Loire-Atlantique, and Loiret. Canine 
leishmaniasis cases contracted in the 
Rhine Valley in Germany (5) and 
the canine cases in Jura argue for a 
northeastern spread of the disease-
endemic area along the Rhone-
Rhine axis and mild microclimatic 
niches. Entomologic and serologic 
surveys will be carried out in summer 
2012 in Jura to look for evidence of 
possible indigenous transmission 
of leishmaniasis. These data should 
supplement the current model of 
northern spread of leishmaniasis-
endemic areas.
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Etymologia: Prion
To the Editor: The January 2012 
Etymologia section might confuse 
readers because it incorrectly reports 
that “prion” describes a noninfectious 
agent (1). In fact, prion—pronounced 
pree’-on—is a term coined in 1982 
by Nobel laureate Stanley Prusiner 
to describe the novel infectious agent 
responsible for scrapie, a transmissble 
neurodegenerative disorder of sheep 
and goats. He proposed his new 
term to underscore that the agents 
are “small proteinaceous infectious 
particles” resistant to procedures that 
attack nucleic acids (2). In his seminal 
article, he summarized experimental 
data indicating that the molecular 
properties of this infectious agent 
differed from those of other infectious 
agents, including viruses, viroids, 
and plasmids; he proposed the word 
prion to replace other terms then in 
circulation, such as “unconventional 
virus” or “unusual slow virus–like 
agent.”
Although Dr. Prusiner acknow-
ledged that he could not exclude the 
possibility of a small nucleic acid 
contained within the interior of the 
prion particle, now 3 decades later, 
no nucleic acid in the agent has yet 
been identifi ed. Increasingly accepted 
in the scientifi c community, prions 
are now considered to be a class of 
misfolded proteinaceous, infectious 
agents responsible for several types 
of human and animal transmissible 
spongiform encephalopathies. Their 
evolving defi ning characteristics 
classically include at least partial 
protease resistance, insolubility, and 
transmissibility. The term, prions, 
usually refers to the complete 
transmissible proteinaceous particles 
in nature or to their classically present, 
transmissible, protease-resistant 
oligomer cores, composed of protein 
fragments with molecular masses of 
≈27–30 kDa.
Adding confusion to the 
terminology, it has become customary 
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